I’m extremely excited to support G Curigliano MD PhD for the next ESMO - Eur. Oncology Presidential Elections - Paolo Tarantino
Università degli Studi di Milano IEO
oncodaily.com/blog/71600.html

#Cancer #ESMO #BCSM #ESMO Presidency #OncoDaily #Oncology

Introducing the newest full Professor at Harvard Medical School, our wonderful colleague and friend Nancy Lin ⁦Nancy Lin, MD⁩!

So proud of her for this amazing and well-deserved honor!! ⁦Dana-Farber’s Breast Oncology Center⁩

Breast cancer and fertility: Dana-Farber study of nearly 200 young women who have survived breast cancer shows most who tried to conceive became pregnant and gave birth.

CC: Ann Partridge MD, MPH Dana-Farber’s Breast Oncology Center

ms.spr.ly/6016Yw5Wn

Las Dras. Prof. Dr. med. Diana Lüftner y Sara Tolaney debatieron con el Dr. Javier Cortes MD PhD sobre el mejor tratamiento para cáncer de mama metastásico RH+/HER2-. 🤩 Resaltaron el papel de los ADCs según guías ESMO y práctica clínica. #ESMObreast24 Entra aquí 👇bit.ly/3KxoZrn

Dr. Kimia Sorouri (Kimia Sorouri, MD, MPH) the study lead author says, “The finding that egg/embryo freezing before treatment was associated with a higher live birth rate underscores the need for accessibility to fertility preservation services for this population.'

Less than a week to what promises to be a terrific ASCO24. Multiple trials with practice changing potential, including with ADCs challenging our HER2 categories, CDK4/6 inhibitors beyond progression, adjuvant IO for TNBC and much more. See you in Chicago next week! #bcsm #ASCO24

Dear Colleagues,
Inviting you to register to this Virtual webinar hosted by our collaborators at VJ Oncology on selected abstracts in #BreastCancer from #ASCO24

Link to Register: us06web.zoom.us/webinar/regist…

Date: June 21, 2024 (5pm CEST)
Chaired by Sara Tolaney 🇺🇸

#ESMOBreast24

‌Congratulations to Nancy Lin, MD, (Nancy Lin, MD) Associate Chief of the Division of Breast Oncology Dana-Farber, who has recently been promoted to Professor of Medicine Harvard Medical School!

Congratulations to Sarah Sammons MD, (Dr Sarah Sammons) Associate Director, Metastatic Breast Cancer Program Dana-Farber, who has recently been promoted to Assistant Professor of Medicine Harvard Medical School!

Congratulations to Wendy Chen, MD, MPH, who has recently been promoted to Institute Physician Dana-Farber!

Congratulations to Leticia Varella, MD, who has recently been promoted to Senior Physician Dana-Farber!

Congratulations to Adrienne Waks, MD, (Ada Waks) Associate Director, Clinical Research, who has recently been promoted to Senior Physician Dana-Farber!

Dear Colleagues,
The OncoAlert 🚨Network Presents OUR Picks of
TOP 🔟Abstracts to be Presented at #ASCO24

This List Curated by:
#OncoAlertAF Leads : Elisa Agostinetto 🇧🇪 Elisabetta Bonzano 🇮🇹 Gil Morgan, MD 🇺🇸
With our distinguished OncoAlert Faculty:
Erika Hamilton, MD 🇺🇸 Stephanie Graff, MD, FACP, FASCO

NANCY!!!!!!!!!!! Yeah!
Nancy Lin, MD Harvard Medical School Professor!
Dana-Farber Dana-FarberNews

I’m excited to support G Curigliano MD PhD for the next ESMO Presidential Elections!

A compassionate clinician and true leader in drug development, Giuseppe has trained an entire generation of young physicians, with a transformative impact in oncology.

Make sure to vote him from May 28!

The names of the candidates running for the ESMO - Eur. Oncology Presidency 2027-2028 have been announced
G Curigliano MD PhD Andres Cervantes FabriceAndre Solange Peters Jean-Yves Blay Evandro de Azambuja, MD, PhD
oncodaily.com/70639.html

#BreastCancer #Cancer Care #Cancer #ESMO #Oncology #OncoDaily

Don’t miss our interactive, case-based discussion to learn about the expanding role of CDK4/6 inhibitors to treat patients with HR-positive/HER2-negative #breastcancer .
Join Erica Mayer in Chicago!

👉 You do not need to be an ASCO registrant to join bit.ly/4aIJX17

Congratulations to Ann Partridge MD, MPH who was selected for a Research Professorship by the American Cancer Society Society. Funding from this award will support expanded research in young adults with breast cancer. CC: Dana-Farber’s Breast Oncology Center pressroom.cancer.org/releases?item=…

🎉Congratulations to Dr. Ann Partridge (Ann Partridge MD, MPH) on this much deserved award!

📰Check out results from the Hurria Older PatiEnts (HOPE) prospective study on functional decline in older #BreastCancer survivors treated with and without chemotherapy and non-cancer controls, out now in Journal of Cancer Survivorship. Rachel Freedman, MD, MPH Jing Ji Cary Gross
▶️▶️pubmed.ncbi.nlm.nih.gov/38678525/